Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
暂无分享,去创建一个
K. Darwiche | M. Schuler | K. Worm | H. Reis | M. Stuschke | M. Wiesweg | T. Herold | B. Schumacher | P. Markus | M. Metzenmacher | S. Kasper | S. Rahmann | C. Aigner | F. Helfritz | A. Abendroth | A. Paul | Heiner Wedemeyer | Linda Sara | Fabian A. Helfritz | K. Schmid | Martin Metzenmacher